Marshall SM, Shearing PA, Alberti KJMicral-test strips evaluated for screening for microalbuminuria. Clin Chem1992;38:588-91.
2.
Marshall SMScreening for microalbuminuria: which measurement?Diabet Med1991;8:706-11.
3.
Mogensen CE, Keane WF, Bennett BH et al. Prevention of diabetic renal disease with special reference to the microbuminuria. Lancet1995;346:1080-4.
4.
Stephenson JM , Fuller JHMicroalbuminuria is not rare before 5 years of IDDM. J Diabetes Complications1994;8:166-73.
5.
Viberti GC, Hill RD, Jarrett RJ et al. Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus. Lancet1982;i:1430-2.
6.
Dineen SF, Gerstein HCThe association of microalbuminuria and mortality in non-insulin dependent diabetes mellitus. Arch Intern Med1997;157:1413-18.
7.
Borch-Johnsen K., Kreiner S.Proteinuria: Value as predictor of cardiovascular mortality in insulin dependent diabetes mellitus. BMJ1987;294:1651-4.
8.
Mattock MB, Barnes DJ, Viberti G. et al. Microalbuminuria and coronary heart disease in NIDDM: An incidence study. Diabetes1998;47:1786-92.
9.
Fioretto P., Stehouer CD, Mauer M. et al. Heterogenous nature of microalbuminuria in NIDDM: studies of endothelial function and renal structure. Diabetologia1998;41:233-6.
10.
Gruden G., Pagano G., Romagnoli R. et al. Thrombomodulin levels in insulin dependent diabetic patients with microalbuminuria. Diabet Med1995;12:258-60.
11.
Greaves M., Malia RG, Goodfellow K. et al. Fibrinogen and Von Willebrand factor in IDDM: relationships to lipid vascular risk factors, blood pressure, glycaemic control and urinary albumin excretion rate. EURODIAB IDDM Complications study. Diabetologia1997;40:698-705.
12.
Hofmann MA, Kohl B., Zumbach MS et al. Hyperhomocysteinemia and endothelial dysfunction in IDDM. Diabetes Care1997;20:1880-6.
13.
Adler A., Matthews D., Harman R. et al. Type II diabetes and death: causes, estimated life expectancy and mortality rates: The United Kingdom Diabetes Study. Diabetes1998;47:A71.
14.
Parving HH, Hommel E., Mathiesen E. et al. Prevalence of microalbuminuria, arterial hypertension, retinopathy and neuropathy in patients with insulin dependent diabetes. BMJ1988;296:156-60.
15.
Lovell HGAngiotensin converting enzyme inhibitors in normotensive diabetic patients with microalbuminuria. Cochran database of systematic reviews. Issue42001.
16.
The National Screening Committee Handbook of population screening programmes. 1st edn (draft). Health Departments of the United Kingdom, 1998.